Cargando…

How to Improve Effectiveness and Adherence to Antihypertensive Drug Therapy: Central Role of Dihydropyridinic Calcium Channel Blockers in Hypertension

Essential hypertension is a complex clinical condition, characterized by multiple and concomitant abnormal activation of different regulatory and contra-regulatory pathophysiological mechanisms, leading to sustained increase of blood pressure (BP) levels. Asymptomatic rise of BP may, indeed, promote...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tocci, Giuliano, Desideri, Giovambattista, Roca, Elisa, Calcullo, Calogero, Crippa, Massimo, De Luca, Nicola, Gaudio, Giovanni Vincenzo, Lonati, Laura Maria, Orselli, Leo, Scuteri, Angelo, Vulpis, Vito, Acone, Benedetto, Zaninelli, Augusto
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2017
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5842506/ https://www.ncbi.nlm.nih.gov/pubmed/29197935 http://dx.doi.org/10.1007/s40292-017-0242-z

Ejemplares similares

Risk of Myocardial Infarction With Combination Antihypertensive Regimens Including a Dihydropyridine Calcium Channel Blocker in Hypertensive Diabetics
por: Anderson, Robert J., et al.
Publicado: (2003)

1,4-Dihydropyridine Antihypertensive Drugs: Recent Advances in Photostabilization Strategies
por: De Luca, Michele, et al.
Publicado: (2019)

Rationale for triple fixed-dose combination therapy with an angiotensin II receptor blocker, a calcium channel blocker, and a thiazide diuretic
por: Volpe, Massimo, et al.
Publicado: (2012)

Dihydropyridine Calcium Channel Blockers and the Risk of Severe COVID-19
por: Mendez, Sean R., et al.
Publicado: (2021)

Antihypertensive effects of new dihydropyridine derivatives on phenylephrine-raised blood pressure in rats
por: Fard, Sara Rowghani Haghighi, et al.
Publicado: (2016)

Updated Recommendations on Cardiovascular Prevention in 2022: An Executive Document of the Italian Society of Cardiovascular Prevention
por: Volpe, Massimo, et al.
Publicado: (2022)

Correction to: Updated Recommendations on Cardiovascular Prevention in 2022: An Executive Document of the Italian Society of Cardiovascular Prevention
por: Volpe, Massimo, et al.
Publicado: (2022)

Dihydropyridine calcium blockers do not interfere with non-rapid eye movement sleep
por: Han, GoEun, et al.
Publicado: (2022)

Dihydropyridine-derived calcium channel blocker as a promising anti-hantavirus entry inhibitor
por: Wang, Bin, et al.
Publicado: (2022)

Herbicidal properties of antihypertensive drugs: calcium channel blockers
por: Abdullah, Hannan Safiyyah Tan Sian Hui, et al.
Publicado: (2021)

The dihydropyridine calcium channel blocker benidipine prevents lysophosphatidylcholine-induced endothelial dysfunction in rat aorta
por: Takayama, Makoto, et al.
Publicado: (2009)

Dihydropyridine Calcium Channel Blockers and Risk of Pancreatic Cancer: A Population‐Based Cohort Study
por: Rouette, Julie, et al.
Publicado: (2022)

Quantitative Structure-Activity Relationship Studies of 4-Imidazolyl- 1,4-dihydropyridines as Calcium Channel Blockers
por: Hadizadeh, Farzin, et al.
Publicado: (2013)

A New Generation of Dihydropyridine Calcium Channel Blockers: Photostabilization of Liquid Formulations Using Nonionic Surfactants
por: Ioele, Giuseppina, et al.
Publicado: (2019)

Dihydropyridine Calcium Channel Blockers Suppress the Transcription of PD-L1 by Inhibiting the Activation of STAT1
por: Pan, Xiaohui, et al.
Publicado: (2021)

Design, synthesis and in silico evaluation of newer 1,4-dihydropyridine based amlodipine bio-isosteres as promising antihypertensive agents
por: Takkar, Priya, et al.
Publicado: (2023)

Safety of beta-blocker and calcium channel blocker antihypertensive drugs in pregnancy: a Mendelian randomization study
por: Ardissino, Maddalena, et al.
Publicado: (2022)

Real-world Antihypertensive Treatment Patterns, Treatment Adherence, and Blood Pressure Control in the Elderly: An Italian Awareness-raising Campaign on Hypertension by Senior Italia FederAnziani, the Italian Society of Hypertension and the Italian Federation of General Practitioners
por: Del Pinto, Rita, et al.
Publicado: (2021)

Impact of angiotensin receptor blocker product recalls on antihypertensive prescribing in Germany
por: Rudolph, Ulrike Maria, et al.
Publicado: (2020)

Effective management of hypertension with dihydropyridine calcium channel blocker-based combination therapy in patients at high cardiovascular risk
por: Haller, H
Publicado: (2008)

Comparative peripheral edema for dihydropyridines calcium channel blockers treatment: A systematic review and network meta‐analysis
por: Liang, Ling, et al.
Publicado: (2022)

Metallated dihydropyridinates: prospects in hydride transfer and (electro)catalysis
por: Parsons, Leo W. T., et al.
Publicado: (2023)

A(2B) adenosine receptor inhibition by the dihydropyridine calcium channel blocker nifedipine involves colonic fluid secretion
por: Asano, Teita, et al.
Publicado: (2020)

Efficacy and safety of two dosages of canrenone as add‐on therapy in hypertensive patients taking ace‐inhibitors or angiotensin II receptor blockers and hydrochlorothiazide at maximum dosage in a randomized clinical trial: The ESCAPE‐IT trial
por: Derosa, Giuseppe, et al.
Publicado: (2016)

Prognostic Value for Incidental Antihypertensive Therapy With β-Blockers in Metastatic Colorectal Cancer
por: Giampieri, Riccardo, et al.
Publicado: (2015)

Ambulatory blood pressure parameters after canrenone addition to existing treatment regimens with maximum tolerated dose of angiotensin-converting enzyme inhibitors/angiotensin II type 1 receptor blockers plus hydrochlorothiazide in uncontrolled hypertensive patients
por: Guasti, Luigina, et al.
Publicado: (2017)

Additional antihypertensive effect of magnesium supplementation with an angiotensin II receptor blocker in hypomagnesemic rats
por: Jin, Kyubok, et al.
Publicado: (2013)

Effects of dihydropyridine calcium channel blockers on oxidized low-density lipoprotein induced proliferation and oxidative stress of vascular smooth muscle cells
por: Zou, Jun, et al.
Publicado: (2012)

Comparison between 1,2-Dihydropyridine and 1,4-Dihydropyridine on Hydride-Donating Ability and Activity
por: Zhang, Jin-Ye, et al.
Publicado: (2022)

Long-acting dihydropyridine calcium-channel blockers and sympathetic nervous system activity in hypertension: A literature review comparing amlodipine and nifedipine GITS
por: Toal, Corey B., et al.
Publicado: (2012)

Hair analysis for beta‐blockers and calcium‐channel blockers by using liquid chromatography‐tandem mass spectrometry as a tool for monitoring adherence to antihypertensive therapy
por: Taus, Francesco, et al.
Publicado: (2022)

Angiotensin II Receptor Blockers (ARBs Antihypertensive Agents) Increase Replication of SARS-CoV-2 in Vero E6 Cells
por: Pires de Souza, Gabriel Augusto, et al.
Publicado: (2021)

New generations of dihydropyridines for treatment of hypertension
por: Wang, Angela L, et al.
Publicado: (2017)

Substituted Dihydropyridine Synthesis by Dearomatization of Pyridines
por: Heusler, Arne, et al.
Publicado: (2021)

Synthesis of Fluorinated 3,6-Dihydropyridines and 2-(Fluoromethyl)pyridines by Electrophilic Fluorination of 1,2-Dihydropyridines with Selectfluor(®)
por: Pikun, Nadiia V., et al.
Publicado: (2020)

Antihypertensive efficacy of the angiotensin receptor blocker azilsartan medoxomil compared with the angiotensin-converting enzyme inhibitor ramipril
por: Bönner, G, et al.
Publicado: (2013)

Centrally acting antihypertensives and alpha-blockers in people at risk of falls: therapeutic dilemmas—a clinical review
por: Welsh, T. J., et al.
Publicado: (2023)

Is there a relationship between blood pressure values and dementia?
por: Desideri, Giovambattista, et al.
Publicado: (2020)

Correlation between cardiovascular risk factors and cognitive decline
por: Desideri, Giovambattista, et al.
Publicado: (2021)

Influence of pHo on calcium channel block by amlodipine, a charged dihydropyridine compound. Implications for location of the dihydropyridine receptor
Publicado: (1989)

Cannot write session to /tmp/vufind_sessions/sess_gjbr38efvq391nn28b42kj28t5